eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank

 
4/2021
vol. 23
 
Share:
Share:
more
 
 
Original paper

Clinical profile of oral pemphigus vulgaris in Thai patients

Ruchadaporn Kaomongkolgit
1
,
Wilairat Sarideechaigul
2, 3, 4
,
Poramaporn Klanrit
2, 3
,
Pensri Phothipakdee
2, 3

1.
Department of Oral Diagnosis, Faculty of Dentistry, Naresuan University, Phitsanulok, Thailand
2.
Department of Oral Biomedical Science, Faculty of Dentistry, Khon Kaen University, Khon Kaen, Thailand
3.
Research Group of Chronic Inflammatory Oral Diseases and Systemic Diseases Associated with Oral Health, Khon Kaen University, Khon Kaen, Thailand
4.
Neuroscience Research and Development Group, Khon Kaen University, Khon Kaen, Thailand
Family Medicine & Primary Care Review 2021; 23(4): 442–446
Online publish date: 2021/12/30
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
 
1. Porro AM, Seque CA, Ferreira MCC, et al. Pemphigus vulgaris. An Bras Dermatol 2019; 94(3): 264–278.
2. Venugopal SS, Murrell DF. Diagnosis and clinical features of pemphigus vulgaris. Immunol Allergy Clin North Am 2012; 32(2): 233–243.
3. Kridin K. Pemphigus group: overview, epidemiology, mortality, and comorbidities. Immunol Res 2018; 66(2): 255–270.
4. Alpsoy E, Akman-Karakas A, Uzun S. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid. Arch Dermatol Res 2015; 307(4): 291–298.
5. Buonavoglia A, Leone P, Dammacco R, et al. Pemphigus and mucous membrane pemphigoid: an update from diagnosis to therapy. Autoimmun Rev 2019; 18(4): 349–358.
6. Melchionda V, Harman KE. Pemphigus vulgaris and pemphigus foliaceus: an overview of the clinical presentation, investigations and management. Clin Exp Dermatol 2019; 44(7): 740–746.
7. Lee YB, Lee JH, Lee SY, et al. Incidence and death rate of pemphigus vulgaris and pemphigus foliaceus in Korea: a nationwide, population-based study (2006–2015). J Dermatol 2018; 45(12): 1396–1402.
8. Iamaroon A, Boonyawong P, Klanrit P, et al. Characterization of oral pemphigus vulgaris in Thai patients. J Oral Sci 2006; 48(1): 43–46.
9. Kulthanan K, Chularojanamontri L, Tuchinda P, et al. Clinical features and course of pemphigus in Thai patients. Asian Pac J Allergy Immunol 2011; 29(2): 161–168.
10. Zhu X, Pan J, Yu Z, et al. Epidemiology of pemphigus vulgaris in the Northeast China: a 10-year retrospective study. J Dermatol 2014; 41(1): 70–75.
11. Yavuz IH, Yavuz GO, Bayram I, et al. Pemphigus in the eastern region of Turkey. Post Dermatol Alergol 2019; 36(4): 455–460.
12. Kridin K, Zelber-Sagi S, Bergman R. Pemphigus vulgaris and pemphigus foliaceus: differences in epidemiology and mortality. Acta Derm Venereol 2017; 97(9): 1095–1099.
13. Serwin AB, Koper M, Flisiak I. Incidence of pemphigus vulgaris and pemphigus foliaceus in North-East Poland (Podlaskie Province) – a 15-year (2001–2015) bicentric retrospective study. Int J Dermatol 2018; 57(8): 933–937.
14. Baican A, Chiorean R, Leucuta DC, et al. Prediction of survival for patients with pemphigus vulgaris and pemphigus foliaceus: a retrospective cohort study. Orphanet J Rare Dis 2015; 10: 48.
15. González DA, Díaz BB, Rodríguez Pérez Mdel C, et al. Sex hormones and autoimmunity. Immunol Lett 2010; 133(1): 6–13.
16. Tiniakou E, Costenbader KH, Kriegel MA. Sex-specific environmental influences on the development of autoimmune diseases. Clin Immunol 2013; 149(2): 182–191.
17. Naseer SY, Gill L, Shah J, et al. Gender-based variability in disease presentation in pemphigus vulgaris. J Drugs Dermatol 2014; 13(10): 1225–1230.
18. Ohki M, Kikuchi S. Nasal, oral, and pharyngolaryngeal manifestations of pemphigus vulgaris: endoscopic ororhinolaryngologic examination. Ear Nose Throat J 2017; 96(3): 120–127.
19. Santoro FA, Stoopler ET, Werth VP. Pemphigus. Dent Clin North Am 2013; 57(4): 597–610.
20. Sar-Pomian M, Rudnicka L, Olszewska M. The significance of scalp involvement in pemphigus: a literature review. Biomed Res Int 2018; 2018: 6154397.
21. Delavarian Z, Layegh P, Pakfetrat A, et al. Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity. J Clin Exp Dent 2020; 12(5): e440–e445.
22. Tavakolpour S. Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol Res 2018; 310(2): 95–106.
23. Sullivan TP, Elgart GW, Kirsner RS. Pemphigus and smoking. Int J Dermatol 2002; 41(8): 528–530.
24. Popescu IA, Statescu L, Vata D, et al. Pemphigus vulgaris – approach and management. Exp Ther Med 2019; 18(6): 5056–5060.
25. Daltaban Ö, Özçentik A, Akman Karakaş A, et al. Clinical presentation and diagnostic delay in pemphigus vulgaris: a prospective study from Turkey. J Oral Pathol Med 2020; 49(7): 681–686.
Copyright: © 2021 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.